PBSV — Pharma-Bio Serv Cashflow Statement
0.000.00%
Last trade - 00:00
- $14.92m
- $1.45m
- $16.98m
- 90
- 65
- 36
- 68
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.09 | 2.05 | -2.09 | 1.01 | 1.31 |
Depreciation | |||||
Non-Cash Items | -0.018 | 0.03 | 3.34 | 0.072 | -0.129 |
Discontinued Operations | |||||
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -4.38 | -0.641 | -0.518 | -0.537 | 0.661 |
Change in Accounts Receivable | |||||
Change in Other Assets | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.21 | 1.53 | 0.805 | 0.592 | 1.89 |
Capital Expenditures | -0.057 | -0.056 | -0.011 | -0.019 | -0.007 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 1.89 | 0.027 | 1.31 | 0 | -4.21 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 1.84 | -0.029 | 1.3 | -0.019 | -4.22 |
Financing Cash Flow Items | 0 | — | — | — | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -0.156 | 0.194 | -1.75 | -3.53 | -1.76 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -0.54 | 1.65 | 0.33 | -3.01 | -4.02 |